155 related articles for article (PubMed ID: 22982977)
21. The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro.
Sborchia M; De Prez EG; Antoine MH; Bienfait L; Indra R; Valbuena G; Phillips DH; Nortier JL; Stiborová M; Keun HC; Arlt VM
Arch Toxicol; 2019 Nov; 93(11):3345-3366. PubMed ID: 31602497
[TBL] [Abstract][Full Text] [Related]
22. The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases.
Stiborová M; Mareš J; Frei E; Arlt VM; Martínek V; Schmeiser HH
Environ Mol Mutagen; 2011 Jul; 52(6):448-59. PubMed ID: 21370283
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
[TBL] [Abstract][Full Text] [Related]
24. Dicoumarol inhibits rat NAD(P)H:quinone oxidoreductase in vitro and induces its expression in vivo.
Stiborova M; Levova K; Barta F; Dracinska H; Sulc M; Hodek P; Frei E; Arlt VM; Schmeiser HH
Neuro Endocrinol Lett; 2014; 35 Suppl 2():123-32. PubMed ID: 25638376
[TBL] [Abstract][Full Text] [Related]
25. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
[TBL] [Abstract][Full Text] [Related]
26. Tanshinone I protects mice from aristolochic acid I-induced kidney injury by induction of CYP1A.
Feng C; Xie X; Wu M; Li C; Gao M; Liu M; Qi X; Ren J
Environ Toxicol Pharmacol; 2013 Nov; 36(3):850-7. PubMed ID: 23981375
[TBL] [Abstract][Full Text] [Related]
27. Induction of biotransformation enzymes by the carcinogenic air-pollutant 3-nitrobenzanthrone in liver, kidney and lung, after intra-tracheal instillation in rats.
Mizerovská J; Dračínská H; Frei E; Schmeiser HH; Arlt VM; Stiborová M
Mutat Res; 2011 Feb; 720(1-2):34-41. PubMed ID: 21167309
[TBL] [Abstract][Full Text] [Related]
28. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.
Stiborová M; Frei E; Hodek P; Wiessler M; Schmeiser HH
Int J Cancer; 2005 Jan; 113(2):189-97. PubMed ID: 15386410
[TBL] [Abstract][Full Text] [Related]
29. Human cytochromes P450 1A1 and 1A2 participate in detoxication of carcinogenic aristolochic acid.
Sistkova J; Hudecek J; Hodek P; Frei E; Schmeiser HH; Stiborova M
Neuro Endocrinol Lett; 2008 Oct; 29(5):733-7. PubMed ID: 18987598
[TBL] [Abstract][Full Text] [Related]
30. A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches.
Stiborová M; Bárta F; Levová K; Hodek P; Schmeiser HH; Arlt VM; Martínek V
Int J Mol Sci; 2015 Nov; 16(11):27561-75. PubMed ID: 26593908
[TBL] [Abstract][Full Text] [Related]
31. Induced expression of cytochrome P450 1A and NAD(P)H:quinone oxidoreductase determined at mRNA, protein, and enzyme activity levels in rats exposed to the carcinogenic azo dye 1-phenylazo-2-naphthol (Sudan I).
Stiborová M; Dračínská H; Martínek V; Svášková D; Hodek P; Milichovský J; Hejduková Ž; Brotánek J; Schmeiser HH; Frei E
Chem Res Toxicol; 2013 Feb; 26(2):290-9. PubMed ID: 23289503
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.
Chen M; Gong L; Qi X; Xing G; Luan Y; Wu Y; Xiao Y; Yao J; Li Y; Xue X; Pan G; Ren J
Toxicol Sci; 2011 Aug; 122(2):288-96. PubMed ID: 21613233
[TBL] [Abstract][Full Text] [Related]
33. CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.
Uno S; Endo K; Ishida Y; Tateno C; Makishima M; Yoshizato K; Nebert DW
Toxicol Appl Pharmacol; 2009 May; 237(1):119-26. PubMed ID: 19285097
[TBL] [Abstract][Full Text] [Related]
34. Skullcapflavone II, a novel NQO1 inhibitor, alleviates aristolochic acid I-induced liver and kidney injury in mice.
Dong YP; Chen SZ; He HS; Sun ZR; Jiang LX; Gu YQ; Zhang Y; Feng F; Chen C; Fan ZC; Chen XF; Wen W; Wang HY
Acta Pharmacol Sin; 2023 Jul; 44(7):1429-1441. PubMed ID: 36697978
[TBL] [Abstract][Full Text] [Related]
35. The environmental pollutant and carcinogen 3-nitrobenzanthrone induces cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in rat lung and kidney, thereby enhancing its own genotoxicity.
Stiborová M; Dracínská H; Mizerovská J; Frei E; Schmeiser HH; Hudecek J; Hodek P; Phillips DH; Arlt VM
Toxicology; 2008 May; 247(1):11-22. PubMed ID: 18329153
[TBL] [Abstract][Full Text] [Related]
36. beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism.
Xiao Y; Xue X; Wu YF; Xin GZ; Qian Y; Xie TP; Gong LK; Ren J
Acta Pharmacol Sin; 2009 Nov; 30(11):1559-65. PubMed ID: 19890363
[TBL] [Abstract][Full Text] [Related]
37. Sex-specific differences in hyperoxic lung injury in mice: role of cytochrome P450 (CYP)1A.
Lingappan K; Jiang W; Wang L; Couroucli XI; Moorthy B
Toxicology; 2015 May; 331():14-23. PubMed ID: 25703676
[TBL] [Abstract][Full Text] [Related]
38. Disruption of the gene for CYP1A2, which is expressed primarily in liver, leads to differential regulation of hepatic and pulmonary mouse CYP1A1 expression and augmented human CYP1A1 transcriptional activation in response to 3-methylcholanthrene in vivo.
Jiang W; Wang L; Kondraganti SR; Fazili IS; Couroucli XI; Felix EA; Moorthy B
J Pharmacol Exp Ther; 2010 Nov; 335(2):369-79. PubMed ID: 20732958
[TBL] [Abstract][Full Text] [Related]
39. The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats.
Stiborová M; Bárta F; Levová K; Hodek P; Frei E; Arlt VM; Schmeiser HH
Arch Toxicol; 2015 Nov; 89(11):2141-58. PubMed ID: 25209566
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches.
Stiborová M; Frei E; Schmeiser HH; Arlt VM; Martínek V
Int J Mol Sci; 2014 Jun; 15(6):10271-95. PubMed ID: 24918288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
